We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Magnetic Technology Creates Easy Endovascular Access

By HospiMedica International staff writers
Posted on 28 Jun 2017
Print article
Image: A new two-catheter system creates a non-traumatic AVF (Photo courtesy of TVA Medical).
Image: A new two-catheter system creates a non-traumatic AVF (Photo courtesy of TVA Medical).
A new study describes how a minimally invasive system uses radiofrequency (RF) energy instead of open surgery to create hemodialysis arteriovenous fistulas (AVFs).

The TVA Medical (Austin, TX, USA) everlinQ endoAVF System utilizes two 6Fr magnetic catheters and a RF energy generator to create a consistent, hemodynamic AVF. The flexible magnetic catheters are first inserted into an artery and a vein in the arm. When in close proximity, the rare earth magnets in each catheter attract to each other, pulling the vessels together. After confirming alignment, a small burst of RF through the venous catheter opens an anastomosis between the artery and vein, creating the AVF. The catheters are then removed, leaving no surgical scar.

Researchers at University Health Network (UHN; Toronto, Canada; University Health Network) conducted a study in 80 patients from nine centers in Canada, Australia and New Zealand, using the system to create AVFs in 98% of participants. Overall, 1.8% of the patients suffered thrombosis or clots within three months, and 10.5% within 12 months, a lower complication rate than reported in AVFs created by open surgery. The researchers reported 12-month primary and cumulative patencies of 69% and 84%, respectively. The study was published on June 14, 2017, in the American Journal of Kidney Disease.

“The results demonstrate that the everlinQ System can create arteriovenous fistulae that are usable for dialysis and resist closure,” said senior author interventional radiologist Dheeraj Rajan, MD, of the UHN joint department of medical imaging. “This novel technology is a substantial benefit to our hemodialysis patients. We can now access veins and arteries that otherwise would not be easily accessible via surgery, and we can do this in a safe, quick way that is easy for our patents to tolerate.”

An AVF is still the most recommended access for kidney disease patients who must undergo dialysis, created by connecting a patient's vein and artery to form a long-lasting site through which blood can be removed and returned. Alternatively, in those unsuitable for a fistula, an arteriovenous graft--a plastic conduit between an artery and a vein--may be used. But many patients prefer a catheter instead, for reasons that include inadequate preparation for dialysis, avoidance of surgery, or fear of needles (since the connection to the dialysis machine via a catheter does not require needles).

Related Links:
TVA Medical
University Health Network

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Digital Pump
Theia
New
Ambulatory Blood Pressure Monitor
ASPEL 308-508 ABPM

Print article

Channels

Critical Care

view channel
Image: The technology allows doctors to detect neurological changes early and intervene more quickly (Photo courtesy of brain4care)

Novel Technology Measures Intracranial Pressure More Accurately and Non-Invasively

Monitoring intracranial pressure (ICP), alongside factors like brain tissue oxygenation, metabolism, and electrical activity, is crucial in neurocritical care. Over the past two centuries, research has... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.